ATTR Amyloidosis

6 registered clinical trials studyying ATTR Amyloidosis — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Orthopaedic Specimen Pathology and Early Diagnosis of ATTR Cardiopathy (ATTR-ORTHO) NCT06367842	Institut Mutualiste Montsouris	—
Recruiting	OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis NCT06355934	AstraZeneca	—
Recruiting	Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis NCT05184088	Life Molecular Imaging GmbH	Phase 3
Recruiting	The Italian Transthyretin Amyloidosis Web-Network NCT05444920	Fondazione IRCCS Policlinico San Matteo di Pavia	—
Recruiting	ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyl NCT04561518	Alnylam Pharmaceuticals	—
Completed	The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated NCT02595983	Alnylam Pharmaceuticals	Phase 2